KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Dividends payables (2016 - 2025)

Historic Dividends payables for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $43.8 million.

  • National Health Investors' Dividends payables rose 1163.27% to $43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.8 million, marking a year-over-year increase of 1163.27%. This contributed to the annual value of $41.1 million for FY2024, which is 524.71% up from last year.
  • As of Q3 2025, National Health Investors' Dividends payables stood at $43.8 million, which was up 1163.27% from $42.7 million recorded in Q2 2025.
  • Over the past 5 years, National Health Investors' Dividends payables peaked at $50.6 million during Q1 2021, and registered a low of $39.0 million during Q3 2022.
  • In the last 5 years, National Health Investors' Dividends payables had a median value of $40.2 million in 2022 and averaged $40.9 million.
  • As far as peak fluctuations go, National Health Investors' Dividends payables tumbled by 1836.8% in 2022, and later soared by 1163.27% in 2025.
  • Over the past 5 years, National Health Investors' Dividends payables (Quarter) stood at $41.3 million in 2021, then fell by 5.37% to $39.0 million in 2022, then grew by 0.05% to $39.1 million in 2023, then increased by 5.25% to $41.1 million in 2024, then rose by 6.59% to $43.8 million in 2025.
  • Its Dividends payables stands at $43.8 million for Q3 2025, versus $42.7 million for Q2 2025 and $42.0 million for Q1 2025.